BCIM
HZNP

British Columbia Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

British Columbia Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,771
Closed -$2.29M – 816
2023
Q3 		$2.29M Buy
19,771
+199
+1% +$21.4K 0.02% 415
2023
Q2 		$2.01M Buy
19,572
+395
+2% +$41.7K 0.02% 465
2023
Q1 		$2.09M Sell
19,177
-82,811
-81% -$9.15M 0.02% 448
2022
Q4 		$11.6M Sell
101,988
-75,135
-42% -$6.24M 0.13% 143
2022
Q3 		$11M Sell
177,123
-3,395
-2% -$237K 0.12% 145
2022
Q2 		$14.4M Sell
180,518
-8,347
-4% -$790K 0.14% 128
2022
Q1 		$19.9M Buy
188,865
+20,583
+12% +$2.01M 0.13% 127
2021
Q4 		$18.1M Sell
168,282
-1,795
-1% -$196K 0.1% 173
2021
Q3 		$18.6M Buy
170,077
+158
+0.1% +$16.4K 0.11% 158
2021
Q2 		$15.9M Buy
+169,919
New +$15.6M 0.1% 191

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

British Columbia Investment Management's HZNP Position: Q4 2023 in Review

British Columbia Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 19,771 shares — an estimated $2.29M sold.

British Columbia Investment Management first reported a position in HZNP in Q2 2021 and held it in 10 quarters. The position peaked at $19.9M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • British Columbia Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • British Columbia Investment Management sold 19,771 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.29M.
  • British Columbia Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 10 quarters.
  • British Columbia Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $19.9M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on British Columbia Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.